C. Biopsy outcomes | n | % | ||
Men undertaking biopsy | 57 | 51 | ||
Median cores per patient | 9 (IQR 5–12) | |||
Total cores | 514 | |||
Cores positive (UCL 2) | 241 | 47 | ||
Biopsy efficiency | 47% | |||
Median cores per lesion | 4 (IQR 4–5) | |||
Median biopsy density (cores/ROI mL) | 10 (IQR 3.5–20) | |||
Cancer detection by man | ||||
Any cancer | 45 | 79 | ||
UCL 2 | 43 | 75 | ||
UCL 1 | 34 | 60 | ||
Gleason ≥3+4 | 43 | 75 | ||
Gleason ≥4+3 | 23 | 40 | ||
Median MCCL (mm) | 7 (IQR 3–10) | |||
Cancer detection by lesion | Any cancer | UCL 2 | UCL 1 | |
Likert 3 (lesions biopsied) | 40 | 13 | 10 | 4 |
Likert 4 (lesions biopsied) | 38 | 24 | 19 | 15 |
Likert 5 (lesions biopsied) | 35 | 35 | 35 | 28 |